ERBB2 and malignant colon neoplasm: Loss of CAV1 was frequently observed in various types of malignancies including colon cancer [26], in which CAV-1 silencing results in activation of multiple survival signals including Src, EGFR, HER2, and the mitogen-activated protein kinase cascade and promotion of cancer transformation and initiation [27].